Diagnosis and treatment of latent tuberculosis infection
Journal of the Korean Medical Association
;
: 11-17, 2019.
Artigo
em Coreano
| WPRIM
| ID: wpr-766545
ABSTRACT
In order to eliminate tuberculosis worldwide by 2050, effective management of latent tuberculosis infection is essential, and policy-makers have begun to recognize the importance of scaling up preventive therapy. The current guideline recommends targeted latent tuberculosis infection testing that identifies high-risk groups based on risk stratification for progression from latent infection to active disease. Both the tuberculin skin test and interferon-gamma releasing assay have a similar diagnostic efficacy for predicting progression to active tuberculosis. The Korean guideline recommends 9-month isoniazid monotherapy as the standard treatment; however, more evidence supports that short course rifampicin-based regimen is both more effective and tolerable than isoniazid monotherapy.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Tuberculina
/
Tuberculose
/
Testes Cutâneos
/
Interferon gama
/
Diagnóstico
/
Tuberculose Latente
/
Testes de Liberação de Interferon-gama
/
Isoniazida
Tipo de estudo:
Estudo diagnóstico
/
Guia de Prática Clínica
/
Estudo prognóstico
Idioma:
Coreano
Revista:
Journal of the Korean Medical Association
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS